Estimating the risk of second primary tumors following cancer treatment

J. R. Harris, C. N. Coleman

Research output: Contribution to journalArticle

Abstract

The findings from this study and other recent case-control studies are reassuring regarding the use of RT in patients with early breast cancer. They indicate that the risk of leukemia secondary to such treatment is extremely small, if present at all. However, it is still possible that the use of RT may be associated with the risk of secondary solid tumors. Since the latency period to the development of these tumors is greater than that for leukemia, additional follow-up is required to be certain about the presence and magnitude of this risk.

Original languageEnglish (US)
Pages (from-to)5-6
Number of pages2
JournalJournal of Clinical Oncology
Volume7
Issue number1
StatePublished - 1989
Externally publishedYes

Fingerprint

Leukemia
Neoplasms
Case-Control Studies
Therapeutics
Breast Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Estimating the risk of second primary tumors following cancer treatment. / Harris, J. R.; Coleman, C. N.

In: Journal of Clinical Oncology, Vol. 7, No. 1, 1989, p. 5-6.

Research output: Contribution to journalArticle

Harris, J. R. ; Coleman, C. N. / Estimating the risk of second primary tumors following cancer treatment. In: Journal of Clinical Oncology. 1989 ; Vol. 7, No. 1. pp. 5-6.
@article{c5ed54ccb3524ad692a6889fdc55233e,
title = "Estimating the risk of second primary tumors following cancer treatment",
abstract = "The findings from this study and other recent case-control studies are reassuring regarding the use of RT in patients with early breast cancer. They indicate that the risk of leukemia secondary to such treatment is extremely small, if present at all. However, it is still possible that the use of RT may be associated with the risk of secondary solid tumors. Since the latency period to the development of these tumors is greater than that for leukemia, additional follow-up is required to be certain about the presence and magnitude of this risk.",
author = "Harris, {J. R.} and Coleman, {C. N.}",
year = "1989",
language = "English (US)",
volume = "7",
pages = "5--6",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "1",

}

TY - JOUR

T1 - Estimating the risk of second primary tumors following cancer treatment

AU - Harris, J. R.

AU - Coleman, C. N.

PY - 1989

Y1 - 1989

N2 - The findings from this study and other recent case-control studies are reassuring regarding the use of RT in patients with early breast cancer. They indicate that the risk of leukemia secondary to such treatment is extremely small, if present at all. However, it is still possible that the use of RT may be associated with the risk of secondary solid tumors. Since the latency period to the development of these tumors is greater than that for leukemia, additional follow-up is required to be certain about the presence and magnitude of this risk.

AB - The findings from this study and other recent case-control studies are reassuring regarding the use of RT in patients with early breast cancer. They indicate that the risk of leukemia secondary to such treatment is extremely small, if present at all. However, it is still possible that the use of RT may be associated with the risk of secondary solid tumors. Since the latency period to the development of these tumors is greater than that for leukemia, additional follow-up is required to be certain about the presence and magnitude of this risk.

UR - http://www.scopus.com/inward/record.url?scp=0024598767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024598767&partnerID=8YFLogxK

M3 - Article

C2 - 2909668

AN - SCOPUS:0024598767

VL - 7

SP - 5

EP - 6

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 1

ER -